| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Cue Biopharma, Inc.'s insiders have reduced their positions by a net 86,790 shares worth roughly $2.4M. In the past 30 days, 0 insiders bought and 3 sold.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), CUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 694.9K | $19.49M | -11,087 | |
| Other | 116.7K | $3.27M | -1,844 | |
| VP | 47.8K | $1.34M | -1,144 | |
| Dir | 32.6K | - | - | |
| Other | 31.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 11,087 | $27.55 | $305,490.35 | -1.6% | - | - | |
| Oct 12, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sell | 1,844 | $28.05 | $51,724.20 | -1.6% | - | - | |
| Oct 12, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 1,144 | $28.05 | $32,089.20 | -2.3% | - | - | |
| Aug 13, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sale+OE | 8,829 | $30.09 | $265,627.93 | -6.9% | - | - | |
| Aug 13, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sale+OE | 5,628 | $30.09 | $169,323.52 | -10.3% | - | - | |
| Aug 13, 2026 | Lin Shao-Lee | Chief Executive Officer | Sale+OE | 58,258 | $27.58 | $1,606,562.42 | -7.6% | - | - | |
| Dec 30, 2025 | Sarraf Pasha | Director | Buy | 323,857 | $0.31 | $99,747.26 | New | -25.3% | - | |
| Dec 16, 2024 | Passeri Daniel R | Chief Executive Officer | Buy | 30,000 | $1.03 | $30,900.00 | +22.3% | -6.9% | -59.8% | |
| Aug 25, 2023 | Suri Anish69 | President And CSO | Buy | 4,000 | $2.76 | $11,040.00 | +3.0% | -12.5% | -72.4% | |
| Aug 14, 2023 | Passeri Daniel R | Chief Executive Officer | Buy | 3,000 | $2.86 | $8,580.00 | +2.3% | -22.1% | -79.3% |